GleamWall
中文EN

CCEL CRYO CELL INTERNATIONAL INC

Services-Misc Health & Allied Services, NEC · NYSE · SEC CIK 862692 · Fiscal year ends 11/30

Financial factors as of 2026-08-31 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-2.0%
TTM net income YoY-310.8%
TTM EPS YoY-380.0%
Revenue 3-yr CAGR-0.1%
Net income 3-yr CAGR—

Margins

Gross margin78.5%
Operating margin0.6%
Net margin-6.2%
FCF margin14.9%
EBITDA margin3.4%

Returns

ROE—
ROA-3.1%
ROIC (approx.)—
Asset turnover0.50x

Leverage & solvency

Liabilities / assets126.3%
Debt / equity—
Current ratio0.86x
Interest coverage0.10x

Cash quality & payout

Operating cash flow / net income-2.53x
Accruals ratio-10.9%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-08-312026Q22026-05-312026Q12026-02-282025Q4*2025-11-302025Q32025-08-312025Q22025-05-312025Q12025-02-282024Q4*2024-11-30
Income statement
Revenue$7.82M$7.78M$7.68M$7.84M$7.83M$7.93M$7.97M$8.02M
Cost of revenue$1.61M$1.68M$1.66M$1.73M$1.80M$1.86M$1.98M$1.64M
Gross profit$6.21M$6.10M$6.03M$6.11M$6.02M$6.07M$5.98M$6.39M
R&D expense$53,624$99,781$65,761$84,784$61,625$131,711$98,143$304,629
SG&A expense$3.78M$4.62M$5.01M$5.45M$3.88M$4.26M$4.64M$6.01M
Operating income$2.19M$1.20M$765,134-$3.97M$1.90M$1.49M$1.06M-$122,347
Interest expense$438,305$441,917$462,709$481,949$538,219$551,126$494,962$745,488
Pretax income$1.83M$827,781$70,309-$4.63M$1.19M$575,103$533,718-$842,434
Income tax$554,958$273,195$23,201-$814,537$436,588$219,318$250,863$1.02M
Net income$1.27M$554,586$47,108-$3.82M$749,408$355,785$282,855-$1.86M
EBITDA$2.38M$1.38M$1.01M-$3.72M$2.09M$1.68M$1.30M$126,650
EPS (basic)0.160.070.01—0.090.040.03—
EPS (diluted)0.160.070.01—0.090.040.03—
Dividends declared per share——————0.25—
Weighted avg. shares (diluted)8.07M8.06M8.06M—8.07M8.13M8.20M—
Balance sheet
Cash & equivalents$1.43M$507,302$249,672$319,031$265,207$137,491$223,122$560,960
Short-term investments$2.80M$2.65M$2.65M$2.98M$2.96M$4.29M$3.26M$2.94M
Receivables$6.83M$6.91M$6.82M$6.85M$6.83M$6.93M$7.21M$7.31M
Inventory$533,557$310,170$356,991$408,794$655,254$676,764$730,467$657,703
Current assets$13.17M$11.30M$11.08M$11.76M$11.67M$13.05M$12.51M$12.55M
PP&E, net$20.54M$20.67M$20.87M$21.03M$21.20M$21.39M$21.73M$21.89M
Goodwill$1.94M$1.94M$1.94M$1.94M$1.94M$1.94M$1.94M$1.94M
Intangibles$829,611$840,765$851,920$863,074$874,229$887,321$904,287$921,254
Total assets$62.30M$60.71M$60.88M$61.73M$63.17M$64.44M$64.38M$64.68M
Current liabilities$15.33M$15.93M$17.76M$19.79M$18.45M$21.75M$21.72M$21.60M
Long-term debt$8.24M$8.28M$8.32M$8.35M$8.39M$8.42M$8.45M$8.48M
Total debt$8.24M$8.28M$8.32M$8.35M$8.39M$8.42M$8.45M$8.48M
Total liabilities$78.70M$78.46M$79.29M$80.33M$78.00M$80.00M$79.04M$77.89M
Shareholders' equity-$16.39M-$17.76M-$18.40M-$18.61M-$14.83M-$15.56M-$14.66M-$13.22M
Net debt$6.81M$7.77M$8.07M$8.03M$8.12M$8.28M$8.23M$7.92M
Shares outstanding8.06M8.06M8.06M8.06M8.06M8.06M8.08M8.08M
Cash flow statement
Operating cash flow$1.14M$1.85M$651,827$1.28M$2.54M$707,014$954,063$2.16M
Capital expenditure$101,879$32,701$67,065$67,226$38,788$62,408$62,053$8,348
Free cash flow$1.04M$1.81M$584,762$1.21M$2.50M$644,606$892,010$2.15M
Investing cash flow-$180,751$35,039$19,104-$289,649$1.10M-$1.50M-$287,484-$1.12M
Financing cash flow-$42,657-$1.62M-$740,290-$937,340-$3.51M$710,155-$1.00M-$677,821
Depreciation & amortization$184,479$184,329$244,212$243,011$185,693$190,102$248,010$248,997
Stock-based compensation$92,514$64,000$158,549$42,903$36,782$40,000$297,392$149,693
Dividends paid$0$0$0$0$0$1.21M$2.02M$2.02M
Share buybacks$0——$0$80,883$88,619$0$0

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.